 | Up a level |
Bokhorst, J. M.; Blank, A.; Lugli, A.; Zlobec, I.; Dawson, H.; Vieth, M.; Rijstenberg, L. L.; Brockmoeller, S.; Urbanowicz, M.; Flejou, J. F.; Kirsch, R.; Ciompi, F.; van der Laak, J. A. W. M.; Nagtegaal, I. D. (2020). Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning. Modern pathology, 33(5), pp. 825-833. Springer Nature 10.1038/s41379-019-0434-2
Kölzer, V.; Karamitopoulou, E.; Dawson, Heather; Kondi-Pafiti, A.; Zlobec, I.; Lugli, A. (2013). Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer. British journal of cancer, 108(10), pp. 2088-2096. Nature Publishing Group 10.1038/bjc.2013.197
Zlobec, I.; Helbling, M.; Dawson, Heather; Kölzer, V. H.; Diamantis Karamitopoulou, E.; Lugli, A. (2013). Hypermethylation of ZEB2 represents a novel mechanism of colorectal cancer progression and is a highly unfavourable prognostic factor in KRAS wild-type tumors. Virchows Archiv, 463(2), p. 139. Springer
Karamitopoulou, E.; Zlobec, I.; Gloor, B.; Lugli, A.; Kölzer, V. (2013). Loss of PTEN expression in tumor microenvironment correlates with aggressive behaviour and detects synergistic roles of tumor and stromal cells in Pancreatic Ductal Adenocarcinoma (PDAC). Virchows Archiv, 463(2), pp. 290-291. Springer
Zlobec, I.; Helbling, M.; Dawson, Heather; Kölzer, V. H.; Karamitopoulou, E.; Lugli, A. (2013). ZEB2 CpG promoter methylation in colorectal cancer is associated with lymph node metastases and invasion in KRAS wild-type patients. Pathologe, 34(6), p. 592. Springer-Medizin-Verlag
Diamantis-Karamitopoulou, E.; Lugli, A.; Gloor, B.; Perren, A.; Zlobec, I. (2013). Decreased CD8+ lymphocytes/tumor budding ratio is associated with metastasis and venous invasion in pancreatic ductal adenocarcinoma (PDAC). Pathologe, 34(6), p. 601. Springer-Medizin-Verlag
Zlobec, I.; Helbling, M.; Karamitopoulou, E.; Dawson, Heather; Kölzer, V. H.; Lugli, A. (2013). CpG promoter hypermethylation of CTNNB1 (B-catenin) and TWIST2 promote a high-grade tumor budding phenotype in colorectal cancer. Pathologe, 34(6), p. 603. Springer-Medizin-Verlag
Dawson, Heather; Hädrich, M.; Kölzer, V.; Inderbitzin, D.; Borner, M.; Zlobec, I.; Lugli, A. (2013). Intratumoral Budding (ITB) in Pre-Operative Biopsies: A Strong Indicator of Lymph Node Positivity in Colon and Rectal Cancer Patients. Laboratory investigation, 93(S1), 148A. Nature Publishing Group
Kölzer, V. H.; Dawson, Heather; Karamitopoulou, E.; Lugli, A.; Zlobec, I. (2013). Loss of RKIP Expression in Colorectal Cancer Is Associated with Activation of the NF-kappa B Signaling Pathway and Epithelial-Mesenchymal Transition. Laboratory investigation, 93(S1), 161A-161A. Nature Publishing Group
Dawson, Heather; Hädrich, M.; Kölzer, V.; Inderbitzin, D.; Borner, M.; Zlobec, I.; Lugli, A. (2013). Intratumoral Budding (ITB) in Pre-Operative Biopsies:A Strong Indicator of Lymph Node Positivity in Colon and Rectal Cancer Patients. Modern pathology, 26, 148A. Nature Publishing Group
Kölzer, V. H.; Dawson, Heather; Karamitopoulou, E.; Lugli, A.; Zlobec, I. (2013). Loss of RKIP Expression in Colorectal Cancer Is Associated with Activation of the NF-kappa B Signaling Pathway and Epithelial-Mesenchymal Transition. Modern pathology, 26(S2), 161A-161A. Nature Publishing Group 10.1038/modpathol.2013.9
